Drug and Medical Device Lawsuits

Elmiron Eye Damage Cases Lead to Multidistrict Litigation Preparations

elmiron lawsuits leading to MDL prepWhen a 2018 study appeared to show a link between Janssen Pharmaceuticals’ bladder infection drug Elmiron and certain types of eye damage, researchers started reviewing the data they had at their own disposal. Elmiron had been in use for decades and had been prescribed to hundreds of thousands of people across the country.

One particularly exhaustive study was conducted by three Kaiser Permanente ophthalmologists in California. The doctors analyzed ...

continue reading...

Flurry of Activity in Late December Could Spell a Long 2021 for Opioid Industry

justice department sues walmart as tennessee enforces drug dealer law against opioid manufacturersA ruling by the Tennessee Supreme Court makes it possible to sue opioid manufacturers under the state’s Drug Dealer Liability Act. The ruling clears the way for a lawsuit to proceed that had been filed on behalf of children that were born addicted to opioids. “If the Baby Doe plaintiffs prove their allegations at trial, a jury could reasonably conclude that ...

continue reading...

Penumbra Jet 7 Xtra Flex Stroke Catheter Recalled

penumbra recalls catheterMedical device manufacturer Penumbra has issued an urgent voluntary recall of the Jet 7 Reperfusion Catheter with Xtra Flex Technology over reports of significant patient injuries, including death. The Jet 7 Xtra Flex catheter and the Jet 7Max configurations are included in the recall action, but the Jet 7 Reperfusion Catheter with Standard Tip is not.

In a release that corresponded with Penumbra’s recall, the Food and Drug Administration ...

continue reading...

FDA Tracking: What Good is a Database if the Data is Inaccurate?

fda drug side effect database outdated and inaccurateA new report out of the Milwaukee Journal Sentinel calls attention to the fact that the FDA’s tracking of drug side effects; many of them dangerous, has been out of date, underreported, and inaccurate for upward of 60 years.

Created in 1960, the system was devised as a way of tracking adverse drug events once the products received their clearance and made it to market. Based largely ...

continue reading...

Judge Approves OxyContin-maker Bankruptcy Settlement Terms

Purdue Pharma bankruptcy terms win judge approval“The Stamford, Connecticut-based company wants to convert into a public benefit corporation that would no longer be owned by members of the Sackler family. The plan calls for the new company to continue making OxyContin, but with the profits going toward fighting the opioid crisis, which has been linked to 470,000 deaths in the U.S. since 2000.”

Whether a more cognitively dissonant combination of words has ever been assembled in the ...

continue reading...

Metformin Recalls Underway as Cancer-causing Compounds Found

metformin recalled after NDMA foundDiabetics who take metformin will want to contact their healthcare providers after multiple recalls of the drug have occurred due to the discovery of elevated levels of a cancer-causing compound. Multiple lots of the extended release version of the drug from multiple manufacturers tested positive for the presence of NDMA, or N-Nitrosodimethylamine, in amounts that exceed FDA regulations.

According to the FDA, humans should be able to tolerate up ...

continue reading...
Page 1 of 131 12345...»